Ensysce Biosciences, Inc. revenue for the last year amounted to 5.21 M USD, the most of which — 5.21 M USD — came from its highest performing source at the moment, Abuse and Overdose Resistant Pain Technology, the year earlier bringing 2.23 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Ensysce Biosciences, Inc. 5.21 M USD, and the year before that — 2.23 M USD.